Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/22/2025

Diagnostic Approach to Gastroesophageal Reflux Disease (GERD)

Primary Diagnostic Categories

  • The American Gastroenterological Association (AGA) guidelines emphasize that 50-60% of patients with suspected extraesophageal reflux (EER) symptoms will not actually have GERD, highlighting the need for careful diagnosis 4
  • Erosive esophagitis with visible mucosal breaks on endoscopy is a key diagnostic category for true GERD 1
  • Non-erosive reflux disease (NERD) with normal endoscopy but pathological acid exposure is another primary diagnostic category for true GERD 2
  • Barrett's esophagus with columnar metaplasia has a prevalence of 0.41% in patients aged 30-49 years, and its diagnosis is crucial in the differential diagnosis of GERD 3

Extraesophageal Reflux (EER) Manifestations

  • Chronic cough related to micro-aspiration or vagally-mediated airway reactions is a common EER presentation 1, 5, 6
  • Laryngeal symptoms such as hoarseness, dysphonia, and throat clearing are also common EER manifestations 1, 6
  • Asthma exacerbations via reflux or reflex pathways can be an EER symptom 5
  • Dental erosions from acid exposure are another possible EER manifestation 6
  • Sinus disease and post-nasal drip can also be associated with EER symptoms 5

Diagnostic Approach Algorithm

  • The AGA recommends a trial of single-dose PPI, titrating to twice daily if needed, for patients with typical reflux symptoms 4, 5
  • Upper endoscopy is recommended if symptoms persist after 8-12 weeks or if alarm features are present 8
  • For patients without typical reflux symptoms but with suspected EER, diagnostic testing should be considered before empiric PPI trial 4, 5
  • Ambulatory reflux monitoring (pH or pH-impedance) is useful for diagnosis when GERD is uncertain, and for evaluating ongoing acid or non-acid reflux in refractory symptoms 4, 9

Key Clinical Pitfalls to Avoid

  • The AGA guidelines advise against relying solely on symptom improvement with PPI as confirmation of GERD, as this may result from placebo effects or mechanisms other than acid suppression 4, 6
  • Laryngoscopy findings such as erythema and edema lack specificity and inter-rater reliability, and should not be used to confirm EER 7
  • Empiric PPI trials should not be continued indefinitely in EER patients, and objective testing should be proceeded with after one 12-week trial without response 4
  • Non-GERD causes should not be overlooked in patients with normal endoscopy and negative reflux testing, and functional disorders, eosinophilic esophagitis, and motility disorders should be considered 2
  • In young patients (<50 years) with uncomplicated reflux symptoms, endoscopy is not needed to exclude Barrett's esophagus given its low prevalence (0.41%) in this age group 3